MEMORIAL SLOAN-KETTERING CANCER CENTER

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 125135
 
  
 
C07K PEPTIDES 7366
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 50156
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 49118
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 4976
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 23217
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2178
 
  
 
C07D HETEROCYCLIC COMPOUNDS 16146
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 8439
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 6101

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0021,259 DYE-STABILIZED NANOPARTICLES AND METHODS OF THEIR MANUFACTURE AND THERAPEUTIC USEFeb 09, 16Jan 25, 18[A61K]
2018/0021,265 COMPOSITIONS AND METHODS FOR NANOPARTICLE-BASED DRUG DELIVERY AND IMAGINGFeb 17, 16Jan 25, 18[A61K]
2018/0008,709 METHODS AND COMPOSITIONS FOR INCREASING SUSCEPTIBILITY TO RADIATION TREATMENT BY INHIBITING SUPPRESSION OF NUMERICAL CHROMOSOMAL INSTABILITY OF CANCER CELLSJan 21, 16Jan 11, 18[A61K, A61N]
2017/0363,618 AGE-MODIFIED CELLS AND METHODS FOR MAKING AGE-MODIFIED CELLSJul 13, 17Dec 21, 17[C12Q, C12N, G01N]
2017/0363,635 Methods of Treating and Prognosing Nonhematopoietic Malignant TumorsDec 04, 15Dec 21, 17[A61K, C12Q, G01N]
2017/0348,234 METHOD AND COMPOSITION FOR TARGETED DELIVERY OF THERAPEUTIC AGENTSJul 23, 15Dec 07, 17[A61K, C12N]
2017/0334,966 ANTI-TUMOR ANTIBODY-TUMOR SUPPRESSOR FUSION PROTEIN COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT OF CANCERAug 01, 17Nov 23, 17[A61K, G01N, C07K]
2017/0304,470 HSP90-TARGETED INFLAMMATION AND INFECTION IMAGING AND THERAPYSep 17, 15Oct 26, 17[A61K, A61B]
2017/0292,111 USE OF BMP4 FOR THYMIC REGENERATIONApr 27, 17Oct 12, 17[A61K, C12N, C07K]
2017/0266,328 METAL(LOID) CHALCOGEN NANOPARTICLES AS UNIVERSAL BINDERS FOR MEDICAL ISOTOPESJul 28, 15Sep 21, 17[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9919037 Immunogenic WT-1 peptides and methods of use thereofJan 15, 14Mar 20, 18[A61K, C07K]
9889135 Companion diagnostic for CDK4 inhibitorsOct 15, 15Feb 13, 18[A61K, C12Q, G01N, A61P]
9890136 Selective HDAC6 inhibitorsDec 23, 14Feb 13, 18[A61K, C07D, C07C]
9878987 HSP70 modulators and methods for making and using the sameMay 13, 15Jan 30, 18[A61K, C07D]
9840533 Compositions and methods for altering second messenger signalingApr 29, 14Dec 12, 17[C07H, A61K, C12Q, C07F, G06F, G06K]
9835737 Autonomous gamma, X-ray, and particle detectorMar 24, 17Dec 05, 17[A61B, G01T]
9814431 Methods and systems for retrospective internal gatingMay 05, 08Nov 14, 17[A61B]
9802995 Antibody multimerization technologiesMar 14, 14Oct 31, 17[A61K, C07K]
9797816 Devices applicable to tissue(s) which facilitates confocal microscopy, optical microscopy, spectroscopy and/or imagingAug 13, 13Oct 24, 17[G01N]
9790283 Antibodies to MUC16 and methods of use thereofSep 10, 15Oct 17, 17[A61K, G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2018/0015,184 METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTSAbandonedJul 12, 16Jan 18, 18[A61K]
2016/0375,060 Methods of Treating Glioblastoma Multiforme by T Cell TherapyAbandonedJun 24, 16Dec 29, 16[A61K, C12N]
2016/0369,006 Fc-ENHANCED ANTI-WT1/HLA ANTIBODYAbandonedNov 07, 14Dec 22, 16[C07K]
2016/0331,750 METHODS FOR TREATMENT OF LYMPHOMAS WITH MUTATIONS IN CELL CYCLE GENESAbandonedJan 07, 16Nov 17, 16[A61K, C12Q, G01N]
2016/0251,722 BRCA2-SPECIFIC MODIFIER LOCUS RELATED TO BREAST CANCER RISKAbandonedSep 25, 15Sep 01, 16[C12Q]
2016/0222,131 ATRX AS A COMPANION DIAGNOSTIC FOR CDK4 INHIBITORSAbandonedApr 21, 16Aug 04, 16[A61K, C12N, G01N, C07K]
2016/0152,725 ANTIGEN-BINDING PROTEINS SPECIFIC FOR HLA-A2-RESTRICTED WILMS TUMOR 1 PEPTIDEAbandonedFeb 25, 15Jun 02, 16[A61K, C07K]
2016/0138,113 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF BRAIN METASTASISAbandonedJun 19, 14May 19, 16[C12Q]
2016/0138,115 METHODS AND CHARACTERISTICS FOR THE DIAGNOSIS OF ACUTE LYMPHOBLASTIC LEUKEMIAAbandonedJun 20, 14May 19, 16[C12Q, G01N, C07K]
2016/0131,651 Gamma-Secretase Substrates and Methods of UseAbandonedMay 01, 15May 12, 16[G01N]
2016/0117,440 SYSTEM AND METHOD FOR AUTOMATED PREDICTION OF VULNERABILITIES IN BIOLOGICAL SAMPLESAbandonedMay 29, 14Apr 28, 16[G06F]
2016/0109,430 METHODS FOR DRUG DISCOVERYAbandonedOct 21, 15Apr 21, 16[G01N]
2016/0015,760 NEWCASTLE DISEASE VIRUSES AND USES THEREOFAbandonedMar 04, 14Jan 21, 16[A61K, C12N, C07K]
2015/0359,913 TETRAZINES/TRANS-CYCLOOCTENES IN SOLID PHASE SYNTHESIS OF LABELED PEPTIDESAbandonedJan 24, 14Dec 17, 15[A61K]
2015/0343,100 BIMODAL FLUOROPHORE-LABELED LIPOSOMES AND ASSOCIATED METHODS AND SYSTEMSAbandonedMay 27, 15Dec 03, 15[A61K]
2015/0344,957 MONITORING TREATMENT OF HISTIOCYTOSIS WITH VEMURAFENIB AND DABRAFENIBAbandonedMay 30, 15Dec 03, 15[A61K, C12Q]
2015/0291,565 INDOLE COMPOUNDS AND THEIR USE AS ANTIMICROBIALSAbandonedNov 12, 13Oct 15, 15[C07D]
2015/0268,248 CELL SELECTIVE PROTEOME LABELINGAbandonedSep 05, 13Sep 24, 15[G01N]
2015/0184,247 GENE EXPRESSION PROFILES ASSOCIATED WITH METASTATIC BREAST CANCERAbandonedApr 22, 13Jul 02, 15[C12Q]
2015/0185,224 PREDICTING BLADDER CANCER RESPONSIVENESS TO BCGAbandonedAug 07, 13Jul 02, 15[C12Q, G01N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.